Expert Meeting on Measurement Criteria for Children's Health Insurance Program; Reauthorization Act Pediatric Quality Measures, 6673-6674 [2010-2873]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 27 / Wednesday, February 10, 2010 / Notices
sroberts on DSKD5P82C1PROD with NOTICES
knowledge of local, State, and Federal
housing programs and how they can be
accessed; or
ii. Short-term or emergency housing
defined as necessary to gain or maintain
access to medical care and must be
related to either:
a. Housing services that include some
type of medical or supportive service:
including, but not limited to, residential
substance abuse or mental health
services (not including facilities
classified as an Institute of Mental
Diseases under Medicaid), residential
foster care, and assisted living
residential services; or
b. Housing services that do not
provide direct medical or supportive
services, but are essential for an
individual or family to gain or maintain
access and compliance with HIV-related
medical care and treatment. Necessity of
housing services for purposes of
medical care must be certified or
documented.
B. Short-term or emergency assistance
is understood as transitional in nature
and for purposes of moving or
maintaining an individual or family in
a long-term, stable living situation.
Thus, such assistance cannot be
permanent and must be accompanied by
a strategy to identify, relocate, and/or
ensure the individual or family is
moved to, or capable of maintaining, a
long-term, stable living situation.
C. Housing funds cannot be in the
form of direct cash payments to
recipients for services and cannot be
used for mortgage payments.
D. The Ryan White HIV/AIDS
Program must be the payer of last resort.
In addition, funds received under the
Ryan White HIV/AIDS Program must be
used to supplement, but not supplant
funds currently being used from local,
State, and Federal Agency programs.
Grantees must be capable of providing
HAB with documentation related to the
use of funds as the payer of last resort
and the coordination of such funds with
other local, State, and Federal funds.
E. Housing-related expenses are
limited to Parts A, B, and D of the Ryan
White HIV/AIDS Program, and are not
allowable expenses under Part C.
Dated: February 5, 2010.
Mary K. Wakefield,
Administrator.
[FR Doc. 2010–2926 Filed 2–9–10; 8:45 am]
BILLING CODE 4165–15–P
VerDate Nov<24>2008
16:21 Feb 09, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Expert Meeting on Measurement
Criteria for Children’s Health Insurance
Program; Reauthorization Act Pediatric
Quality Measures
AGENCY: Agency for Healthcare Research
and Quality (AHRQ).
ACTION: Notice of public meeting.
SUMMARY: This notice announces a
meeting to identify measurement
criteria for use in carrying out the
Pediatric Quality Measures Program
(PQMP) under Section 1139A(b) of the
Social Security Act as enacted in the
Children’s Health Insurance Program
Reauthorization Act (CHIPRA).
DATES: The meeting will be held on
Wednesday, February 24, 2010, from 10
a.m. to 5 p.m. and Thursday, February
25, 2010, from 8 a.m. to 4 p.m.
ADDRESSES: Agency for Healthcare
Research and Quality Eisenberg
Building, 540 Gaither Rd., Rockville,
MD 20850 and by public webcast.
FOR FURTHER INFORMATION CONTACT:
Maushami DeSoto, Agency for
Healthcare Research and Quality, 540
Gaither Road, Rockville, Maryland
20850, (301) 427–1546. For press-related
information, please contact Karen
Migdail at (301) 427–1855.
If sign language interpretation or other
reasonable accommodation for a
disability is needed, please contact Mr.
Michael Chew, Director, Office of Equal
Employment Opportunity Program,
Program Support Center, on (301) 443–
1144, no later than February 20, 2010.
SUPPLEMENTARY INFORMATION:
I. Purpose
In early 2009, CHIPRA (Pub. L. 111–
3) reauthorized the Child Health
Insurance Program (CHIP) originally
established in 1997, and in Title IV of
the law, added a number of new
provisions designed to improve health
care quality and outcomes for children.
AHRQ is working closely with the
Centers for Medicare and Medicaid
Services (CMS) and the CHIPRA Federal
Quality Workgroup in implementing
these provisions. For more information
about AHRQ’s role in carrying out the
quality provisions of CHIPRA, and for a
list of an initial core set of children’s
healthcare quality measures voluntary
use by Medicaid programs and
Children’s Health Insurance Programs
and the health plans and providers of
care that the programs engage with,
mandated by the Act, that has been
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
6673
identified and posted for public
comment, see https://www.ahrg.gov/
chip/chipraact.htm.
CHIPRA further directed the Secretary
to establish a Pediatric Quality
Measures Program (PQMP) to strengthen
and expand the initial core measure set
required under its section 401(a). The
statutory goal of the PQMP is to produce
an improved core set of children’s
healthcare quality measures for use by
public and private programs, health
insurers, providers and patients, by
January 1, 2013. In order to achieve this
goal, measurement criteria to develop
and enhance pediatric health care
measures need to be identified and
framed for use by those who will be
developing and enhancing the measures
under the PQMP. The PQMP objectives
are to: Expand, improve and strengthen
the initial core measure set and existing
pediatric measures used by public and
private health care purchasers and
advance the development of new and
emerging quality measures; and thereby,
increase the portfolio of evidence-based
and consensus-based, pediatric quality
measures available to public and private
purchasers of children’s health care
services, providers, and consumers as
well as for use by policymakers at all
political levels, including use in
mandated reports to Congress on
voluntary State reporting and on any
need for further legislation.
In accordance with statutory
requirements, the measures to be
developed or enhanced under this
program will cover a range of pediatric
preventive services, treatments and
services for both acute and chronic
conditions, including health services to
correct or ameliorate the effects of
physical and mental conditions; and
health services to aid in the growth and
development of children with special
health care needs; and measure and
duration of health care coverage. Said
measures are to be designed to ensure
that data collected are comparable at the
State, health plan and provider levels,
risk-adjusted if appropriate, and
periodically updated. In addition,
pursuant to section 401(s) of CHIPRA,
measures are to be able to identify
disparities by race and ethnicity,
socioeconomic status, and special
healthcare needs.
II. Agenda
On Wednesday, February 24, 2010,
the meeting will convene at 10 a.m. The
meeting will focus on engaging invited
experts and public participants in
identifying criteria for pediatric quality
measures to be used by PQMP grant and
contract program awardees beginning in
September 2010. The agenda will cover
E:\FR\FM\10FEN1.SGM
10FEN1
6674
Federal Register / Vol. 75, No. 27 / Wednesday, February 10, 2010 / Notices
discussions of key measure criteria in
existence and participants will be asked
to identify criteria suitable for the
measure development and enhancement
work to be supported by the PQMP
program.
A more specific proposed agenda and
instructions for public access to the
meeting will be posted before the
meeting at https://www.ahrg.gov/chip/
chipraact.htm. The final agenda,
including the time for public comment
during the meeting, will be available on
the AHRQ Web site at https://
www.ahrg.gov/chip/chipraact.htm no
later than February 14, 2010. A
transcript of the meeting will be
available within 21 business days after
the meeting.
Dated: February 2, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–2873 Filed 2–9–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
February 25, 2010, 1 p.m. to February
25, 2010, 4 p.m., National Institutes of
Health, 6701 Rockledge Drive, Bethesda,
MD, 20892 which was published in the
Federal Register on February 1, 2010,
75 FR 5092.
The meeting will be held February 22,
2010, from 11 a.m. to 2 p.m. The
meeting location remains the same.
The meeting is closed to the public.
Dated: February 2, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–2886 Filed 2–9–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on DSKD5P82C1PROD with NOTICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Nov<24>2008
16:21 Feb 09, 2010
Jkt 220001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Auditory, Pain and
Chemosensation.
Date: March 1–2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Lynn E. Luethke, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5166,
MSC 7844, Bethesda, MD 20892, (301) 806–
3323, luethkel@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Drug Discovery and Development.
Date: March 1–2, 2010.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Sergei Ruvinov, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892. 301–435–
1180. ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Microvascular Interactions.
Date: March 3, 2010.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Manjit Hanspal, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4138,
MSC 7804, Bethesda, MD 20892, 301–435–
1195, hanspalm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Fellowship:
Chemical and Bioanalytical Sciences.
Date: March 4, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Denise Beusen, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
MSC 7806, Bethesda, MD 20892, (301) 435–
1267, beusend@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Topics in Cancer Research.
Date: March 8–9, 2010.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Eun Ah Cho, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6202,
MSC 7804, Bethesda, MD 20892, (301) 451–
4467, choe@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Program
Project: National Radiotracer Resource
Center.
Date: March 14–16, 2010.
Time: 6 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Parkway Hotel, 4550 Forest
Park Avenue, St. Louis, MO 63108.
Contact Person: Keith Crutcher, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5207,
MSC 7846, Bethesda, MD 20892, 301–435–
1278, crutcherka@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group,
Behavioral and Social Consequences of HIV/
AIDS Study Section.
Date: March 15–16, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marina del Rey Marriott, 4100
Admiralty Way, Marina del Rey, CA 90292.
Contact Person: Mark P. Rubert, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5218,
MSC 7852, Bethesda, MD 20892, 301–806–
6596, rubertm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR Panel:
Cancer Health Disparities.
Date: March 15–16, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Monaco, 700 F Street, NW.,
Washington, DC 20001.
Contact Person: Nywana Sizemore, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6204,
MSC 7804, Bethesda, MD 20892, 301–435–
1718, sizemoren@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: CDIN and CNN Member
Applications II.
Date: March 15, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
E:\FR\FM\10FEN1.SGM
10FEN1
]]>Agencies
[Federal Register Volume 75, Number 27 (Wednesday, February 10, 2010)]
[Notices]
[Pages 6673-6674]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-2873]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Expert Meeting on Measurement Criteria for Children's Health
Insurance Program; Reauthorization Act Pediatric Quality Measures
AGENCY: Agency for Healthcare Research and Quality (AHRQ).
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a meeting to identify measurement
criteria for use in carrying out the Pediatric Quality Measures Program
(PQMP) under Section 1139A(b) of the Social Security Act as enacted in
the Children's Health Insurance Program Reauthorization Act (CHIPRA).
DATES: The meeting will be held on Wednesday, February 24, 2010, from
10 a.m. to 5 p.m. and Thursday, February 25, 2010, from 8 a.m. to 4
p.m.
ADDRESSES: Agency for Healthcare Research and Quality Eisenberg
Building, 540 Gaither Rd., Rockville, MD 20850 and by public webcast.
FOR FURTHER INFORMATION CONTACT: Maushami DeSoto, Agency for Healthcare
Research and Quality, 540 Gaither Road, Rockville, Maryland 20850,
(301) 427-1546. For press-related information, please contact Karen
Migdail at (301) 427-1855.
If sign language interpretation or other reasonable accommodation
for a disability is needed, please contact Mr. Michael Chew, Director,
Office of Equal Employment Opportunity Program, Program Support Center,
on (301) 443-1144, no later than February 20, 2010.
SUPPLEMENTARY INFORMATION:
I. Purpose
In early 2009, CHIPRA (Pub. L. 111-3) reauthorized the Child Health
Insurance Program (CHIP) originally established in 1997, and in Title
IV of the law, added a number of new provisions designed to improve
health care quality and outcomes for children. AHRQ is working closely
with the Centers for Medicare and Medicaid Services (CMS) and the
CHIPRA Federal Quality Workgroup in implementing these provisions. For
more information about AHRQ's role in carrying out the quality
provisions of CHIPRA, and for a list of an initial core set of
children's healthcare quality measures voluntary use by Medicaid
programs and Children's Health Insurance Programs and the health plans
and providers of care that the programs engage with, mandated by the
Act, that has been identified and posted for public comment, see https://www.ahrg.gov/chip/chipraact.htm.
CHIPRA further directed the Secretary to establish a Pediatric
Quality Measures Program (PQMP) to strengthen and expand the initial
core measure set required under its section 401(a). The statutory goal
of the PQMP is to produce an improved core set of children's healthcare
quality measures for use by public and private programs, health
insurers, providers and patients, by January 1, 2013. In order to
achieve this goal, measurement criteria to develop and enhance
pediatric health care measures need to be identified and framed for use
by those who will be developing and enhancing the measures under the
PQMP. The PQMP objectives are to: Expand, improve and strengthen the
initial core measure set and existing pediatric measures used by public
and private health care purchasers and advance the development of new
and emerging quality measures; and thereby, increase the portfolio of
evidence-based and consensus-based, pediatric quality measures
available to public and private purchasers of children's health care
services, providers, and consumers as well as for use by policymakers
at all political levels, including use in mandated reports to Congress
on voluntary State reporting and on any need for further legislation.
In accordance with statutory requirements, the measures to be
developed or enhanced under this program will cover a range of
pediatric preventive services, treatments and services for both acute
and chronic conditions, including health services to correct or
ameliorate the effects of physical and mental conditions; and health
services to aid in the growth and development of children with special
health care needs; and measure and duration of health care coverage.
Said measures are to be designed to ensure that data collected are
comparable at the State, health plan and provider levels, risk-adjusted
if appropriate, and periodically updated. In addition, pursuant to
section 401(s) of CHIPRA, measures are to be able to identify
disparities by race and ethnicity, socioeconomic status, and special
healthcare needs.
II. Agenda
On Wednesday, February 24, 2010, the meeting will convene at 10
a.m. The meeting will focus on engaging invited experts and public
participants in identifying criteria for pediatric quality measures to
be used by PQMP grant and contract program awardees beginning in
September 2010. The agenda will cover
[[Page 6674]]
discussions of key measure criteria in existence and participants will
be asked to identify criteria suitable for the measure development and
enhancement work to be supported by the PQMP program.
A more specific proposed agenda and instructions for public access
to the meeting will be posted before the meeting at https://www.ahrg.gov/chip/chipraact.htm. The final agenda, including the time
for public comment during the meeting, will be available on the AHRQ
Web site at https://www.ahrg.gov/chip/chipraact.htm no later than
February 14, 2010. A transcript of the meeting will be available within
21 business days after the meeting.
Dated: February 2, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-2873 Filed 2-9-10; 8:45 am]
BILLING CODE 4160-90-M
